VYALEV is the first and only subcutaneous 24-hour continuous infusion of levodopa-based therapy for the treatment of motor fluctuations in advanced Parkinson's disease
MedGenome reaffirms its commitment to broaden access to quality and affordable genetic solutions for all
Buckley served as Chairman and Chief Executive Officer at Vanguard from 2018 until his retirement in 2024
The market size of Aspart in India is currently estimated over Rs. 260 crore with only 2 players
Lyka has received the CDSCO approval for manufacturing and marketing of Pregabalin Gel 8% w/w
Declan brings over 25 years of expertise in the pharmaceutical and biotech sectors
The partnership marks a pivotal step towards developing new therapies for combating Sickle Cell Disease
Approval is based on Phase III INAVO120 results, showing the Itovebi (inavolisib)-based regimen more than doubled progression-free survival compared with palbociclib and fulvestrant alone in the first-line setting
We now rank 3rd in pharmaceutical production by volume and 14th by value
The acquisition will strengthen the overall company’s position as leading global CRO services partner
Subscribe To Our Newsletter & Stay Updated
